The Oxford-AstraZeneca Corona vaccine can be approved in the UK soon after Christmas. Senior British government officials have indicated that the vaccine may be approved on 28 or 29 December by the country’s drug regulatory agency, the Medicine and Healthcare Products Regulatory Agency (MHRA). British media Daily Mail gave this information.
According to the report, the regulatory body is awaiting final notice from scientists at the University of Oxford. This information will be submitted on Monday. A MHRA spokesman said the review was ongoing. However, he did not object to the deadline.
More than 140,000 people in Great Britain have already received the Pfizer-Bioentech Corona vaccine. Earlier this month, regulators approved the vaccine for emergency use. The Pfizer vaccine is to be stored at a temperature of minus 60 ° C. But Oxford vaccines can be stored at room temperature.
The former UK health minister warned on Saturday that the remaining vaccine doses of Pfizer-Bioentech would be administered in January. No vaccine shipment will be available before March. As a result, the ongoing vaccination program may be deadlocked.
He said that the Oxford vaccine could bring a big change.
According to a report in the British newspaper The Daily Telegraph, mass vaccination programs at football stadiums and race courses across the UK will begin early next year after obtaining regulatory approval. Subsequently, 20 million at-risk people in the country will be vaccinated in March. This will pave the way for easing some restrictions.
The UK government has ordered 100 million doses of the Oxford-AstraZeneca vaccine. The Daily Mail reports that United Kingdom approval will boost the morale of countries that have already ordered vaccines.